0
0
May 31, 2025 — A new study published in Radiology: Imaging Cancer highlights the significant benefits of routine breast cancer screening, revealing that patients whose breast cancer is detected through regular mammography have markedly better clinical outcomes than those diagnosed after developing symptoms.
Key Findings
Researchers, led by Dr. Jean M. Seely of the University of Ottawa, conducted a retrospective analysis of 821 patients aged 40 and older who were diagnosed with breast cancer in 2016. The study found that:
-
Screening-detected breast cancers were associated with a lower likelihood of advanced disease, reduced need for mastectomy, and a lower risk of death compared to cancers detected due to symptoms.
-
Symptom-detected cancers were more common in women aged 40–49 and over 75, with 72.9% and 70.4% of cases in these age groups, respectively, being found after symptoms appeared.
-
Mortality rates were higher among patients who were not regularly screened. Nearly 20% of patients died within 6.7 years of diagnosis, with half of those deaths attributed to breast cancer. Patients with symptom-detected cancers had a 63% higher risk of death.
Implications for Screening Guidelines
The findings come as the United States Preventive Services Task Force (USPSTF) recently updated its guidelines, recommending biennial breast cancer screening for women aged 40 to 75 at average risk. In Canada, the current recommendation is screening every two to three years for women aged 50 to 74.
Dr. Seely emphasized the potential impact of these results on public health policy, stating, “The results of this study will likely support the move to reduce the breast cancer screening age to 40 in the U.S. and Canada.” She also noted ongoing efforts in Canada to establish a unified national screening policy.
Reducing Barriers to Screening
The researchers concluded that lowering barriers to breast cancer screening, particularly for women aged 40 to 74, could significantly improve patient outcomes and reduce mortality. The study also suggests that women over 75 may benefit from continued screening, as they are more likely to be diagnosed at a symptomatic stage requiring more intensive treatment.
Disclaimer:
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or screening recommendations.
Citations:
